Differentiate Your Concierge Practice
Precision medication guidance can further distinguish your concierge practice
- Stand out in the crowded concierge space (retain and attract patients)
- Enhance the personalized care experience
- Streamline medication selection, increasing efficiency while improving outcomes
- Deliver improved medication management and improved patient safety
Set Your Concierge Practice Apart with Personalized Medicine through PGx
Using an individual’s genetic profile as a guide, PGx testing enables informed clinicians to move beyond trial and error prescribing, furthering evidence and science based care.
This thoughtful and precise approach can increase the effectiveness of medication regimens, reduce incidence of polypharmacy, and reduce the risk of adverse drug reactions (ADR). Utilization of precision medicine tools helps to set your practice apart with enhanced healthcare safety, quality and efficiency – setting the stage for more positive patient outcomes.
• Personalized Treatment
• Preventive Care
• Reduced Adverse Reactions
• Enhanced Patient Outcomes
• Improved Medicine Adherence
• Increased Practice Differentiation
Pharmacogenomic (PGx) testing identifies variations in genes that are known to affect an individual’s drug metabolism and response, allowing you to truly know your patient. These variations can affect how the body absorbs, activates, distributes and metabolizes drugs, which can in turn impact efficacy and safety.
effective
nontoxic
effective
toxic
ineffective
nontoxic
ineffective
toxic
An individual is screened for genetic drug responses.
Broad spectrum panel review or specific category panels.
General
Medicine A
Medicine B
Medicine C
Medicine D
Antidepressants
Antidepressant A
Antidepressant B
Antidepressant B
Antidepressant A
■ Use as directed
■ Ineffective and/or prompts adverse reaction
Applied DNA Clinical Labs, LLC (“ADCL”) is a NYSDOH CLEP-permitted, Clinical Laboratory Improvement Amendments (“CLIA”)-certified clinical laboratory certified to perform high-complexity testing. The TR8 test was developed, and its performance characteristics were determined by ADCL. The TR8 test has not been cleared or approved by the U.S. Food and Drug Administration. The TR8 test is intended for clinical purposes and is available via prescription only.
The Optimized TR8™ PGx panel is designed to meet the demands of today’s dynamic healthcare environment by integrating the latest pharmacogenomic research with clinical trends. The panel covers a comprehensive range of genetic variants relevant to drug metabolism and response, allowing healthcare providers to make informed decisions tailored to individual patient profiles.